Publications

Heterogeneity of Residual Disease After Neoadjuvant Systemic Therapy in Breast Cancer

 76
Heterogeneity of Residual Disease After Neoadjuvant Systemic Therapy in Breast Cancer

Tags:

Previous Article

Defining microglial-synapse interactions

Next Article

Clinical sequelae of gut microbiome development and disruption in hospitalized p...

Related Posts

Untangling the multifaceted VTA responses to stress

Untangling the multifaceted VTA responses to stress

 57

Nanoparticle-based itaconate treatment recapitulates low-cholesterol/low-fat diet-induced atherosclerotic plaque resolution

Nanoparticle-based itaconate treatment recapitulates lo...

 101

SPL13 controls a root apical meristem phase change by triggering oriented cell divisions

SPL13 controls a root apical meristem phase change by t...

 75